Tissue factor pathway inhibitor is highly susceptible to chymase‐mediated proteolysis
Authors:
Open Access
- 17 May 2007
- journal article
- Published by Wiley in The FEBS Journal
- Vol. 274 (12) , 3065-3077
Abstract
Tissue factor pathway inhibitor (TFPI) is a multivalent Kunitz-type protease inhibitor that primarily inhibits the extrinsic pathway of blood coagulation. It is synthesized by various cells and its expression level increases in inflammatory environments. Mast cells and neutrophils accumulate at sites of inflammation and vascular disease where they release proteinases as well as chemical mediators of these conditions. In this study, the interactions between TFPI and serine proteinases secreted from human mast cells and neutrophils were examined. TFPI inactivated human lung tryptase, and its inhibitory activity was stronger than that of antithrombin. In contrast, mast cell chymase rapidly cleaved TFPI even at an enzyme to substrate molar ratio of 1 : 500, resulting in markedly decreased TFPI anticoagulant and anti-(factor Xa) activities. N-Terminal amino-acid sequencing and MS analyses of the proteolytic fragments revealed that chymase preferentially cleaved TFPI at Tyr159-Gly160, Phe181-Glu182, Leu89-Gln90, and Tyr268-Glu269, in that order, resulting in the separation of the three individual Kunitz domains. Neutrophil-derived proteinase 3 also cleaved TFPI, but the reaction was much slower than the chymase reaction. In contrast, α-chymotrypsin, which shows similar substrate specificities to those of chymase, resulted in a markedly lower level of TFPI degradation. These data indicate that TFPI is a novel and highly susceptible substrate of chymase. We propose that chymase-mediated proteolysis of TFPI may induce a thrombosis-prone state at inflammatory sites.Keywords
This publication has 61 references indexed in Scilit:
- Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin GBlood, 2006
- Albumin Is a Substrate of Human ChymaseJournal of Biological Chemistry, 2003
- Glycosyl Phosphatidylinositol Anchorage of Tissue Factor Pathway InhibitorCirculation, 2003
- Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8Biochemical Journal, 2002
- Structural Mechanism for Heparin-Binding of the Third Kunitz Domain of Human Tissue Factor Pathway Inhibitor,Biochemistry, 2001
- Human Ryudocan from Endothelium-like Cells Binds Basic Fibroblast Growth Factor, Midkine, and Tissue Factor Pathway InhibitorJournal of Biological Chemistry, 1996
- Amino Acid Sequence and Carbohydrate Structure of a Recombinant Human Tissue Factor Pathway Inhibitor Expressed in Chinese Hamster Ovary Cells: One N- and Two O-Linked Carbohydrate Chains Are Located between Kunitz Domains 2 and 3 and One N-Linked Carbohydrate Chain Is in Kunitz Domain 2Biochemistry, 1996
- Effect of Heparin on the Inhibition of Factor Xa by Tissue Factor Pathway Inhibitor: A Segment, Gly212-Phe243, of the Third Kunitz Domain Is a Heparin-Binding SiteBiochemistry, 1995
- Limited proteolysis of Cl‐inhibitor by chymotrypsin‐like proteinasesFEBS Letters, 1989
- Inactivation of bradykinin and kallidin by cathepsin G and mast cell chymaseBiochemical and Biophysical Research Communications, 1985